Role of 11C-choline positron emission tomography/computed tomography in evaluating patients affected by prostate cancer with suspected relapse due to prostate-specific antigen elevation

Japanese Journal of Radiology

Volumn 29, Issue 6, 2011, Pages 394-404

  Bertagna, Francesco ^a   Abuhilal, Muhannad ^b   Bosio, Giovanni ^a   Simeone, Claudio ^a   Rossini, Pierluigi ^a   Pizzocaro, Claudio ^a   Orlando, Emanuela ^c   Finamanti, Marco ^b   Biasiotto, Giorgio ^a   Rodella, Carlo ^d   Cosciani Cunico, Sergio ^a   Giubbini, Raffaele ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Urology Department   (Italy)

^c 1st Division of Radiology   (Italy)

^d Medical Physics Department   (Italy)

Author keywords

11C choline; PET; Prostate cancer

Indexed keywords

CHOLINE C 11; PROSTATE SPECIFIC ANTIGEN; CHOLINE; CONTRAST MEDIUM; DIAGNOSTIC AGENT; GADOBUTROL; ORGANOMETALLIC COMPOUND;

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE SURGERY; SENSITIVITY AND SPECIFICITY; BIOASSAY; BLOOD; METHODOLOGY; PATHOLOGY; PROSTATE TUMOR; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE;

AGED; CHOLINE; CONTRAST MEDIA; ENDPOINT DETERMINATION; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 80052692151     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-011-0570-1     Document Type: Article

References (30)

1. S.F. Shariat P.T. Scardino H. Lilja 2008 Screening for prostate cancer: an update Can J Urol 15 4363 4374 19046489
2. A.M. Lin E.J. Small 2008 Prostate cancer update: 2007 Curr Opin Oncol 20 294 299 18391629 10.1097/CCO.0b013e3282f8b075 (Pubitemid 351507550)
3. H. Jadvar A. Alavi 2009 Role of imaging in prostate cancer PET Clin 4 135 138 20161047 10.1016/j.cpet.2009.05.003
4. G.A. Lin D.S. Aaronson S.J. Knight P.R. Carroll R.A. Dudley 2009 Patient decision aids for prostate cancer treatment. a systematic review of the literature CA Cancer J Clin 59 379 390 19841280 10.3322/caac.20039
5. A.V. D'Amico R. Whittington S.B. Malkowicz D. Schultz K. Blank G.A. Broderick, et al. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969 974 9749478 10.1001/jama.280.11.969 (Pubitemid 28445094)
6. P.M.R. Cooperberg J.M. Broering P.W. Kantoff P.R. Carroll 2007 Contemporary trends in low risk prostate cancer: risk assessment and treatment J Urol 178 S14 S19 17644125 10.1016/j.juro.2007.03.135 (Pubitemid 47224952)
7. A. Bill-Axelson L. Holmberg F. Filén M. Ruutu H. Garmo C. Busch, et al. 2008 Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial J Natl Cancer Inst 100 1144 1154 18695132 10.1093/jnci/djn255
8. T.J. Wilt R. MacDonald I. Rutks T.A. Shamliyan B.C. Taylor R.L. Kane 2008 Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer Ann Intern Med 148 435 448 18252677 (Pubitemid 351665443)
9. J.P. Droz L. Balducci M. Bolla M. Emberton J.M. Fitzpatrick S. Joniau, et al. 2010 Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults Crit Rev Oncol Hematol 73 68 91 19836968 10.1016/j.critrevonc.2009.09.005
10. 11C-choline PET/CT Radiology 244 797 806 17652190 10.1148/radiol.2443061063 (Pubitemid 47292091)
11. A. Jemal T. Murray E. Ward A. Samuels R.C. Tiwari A. Ghafoor, et al. 2005 Cancer statistics, 2005 CA Cancer J Clin 55 10 30 15661684 10.3322/canjclin.55. 1.10 (Pubitemid 40310185)
12. D.B. Chism A.L. Hanlon E.M. Horwitz S.J. Feigenberg A. Pollack 2004 A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy Int J Radiat Oncol Biol Phys 59 380 385 15145151 10.1016/j.ijrobp.2003.10.059 (Pubitemid 38622589)
13. W.J. Catalona D.S. Smith T.L. Ratliff J.W. Basler 1993 Detection of organ-confined prostate cancer is increased through prostatespecific antigen-based screening JAMA 270 948 954 7688438 10.1001/jama.270.8.948 1:STN:280:DyaK3szksleruw%3D%3D (Pubitemid 23244733)
14. Z.A. Dotan 2008 Bone imaging in prostate cancer Nat Clin Prac Urol 5 434 444 10.1038/ncpuro1190
15. S. Modoni E. Calo G. Nardella G. Ritrovato V. Frusciante 1997 PSA and bone scintigraphy Int J Biol Markers 12 158 161 9582605 1:STN:280: DyaK1c3ktlCisw%3D%3D (Pubitemid 28190912)
16. C.T. Lee J.E. Oesterling 1997 Using prostate-specific antigen to eliminate the staging radionuclide bone scan Urol Clin North Am 24 389 394 9126236 10.1016/S0094-0143(05)70385-2 1:STN:280:DyaK2s3ntFartw%3D%3D (Pubitemid 27169263)
17. H. Vees F. Buchegger S. Albrecht H. Khan D. Husarik H. Zaidi, et al. 2007 (18)F-choline and/or (11)C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy BJU Int 99 1415 1420 17428249 10.1111/j.1464-410X.2007.06772.x 1:CAS:528:DC%2BD2sXotFansLw%3D (Pubitemid 47164795)
18. B.J. Krause M. Souvatzoglou M. Tuncel K. Herrmann A.K. Buck C. Praus, et al. 2008 The detection rate of [(11)C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer Eur J Nucl Med Mol Imaging 35 18 23 17891394 10.1007/s00259-007-0581-4 1:CAS:528: DC%2BD2sXhsVSmtLbO (Pubitemid 350234152)
19. 11C]choline positron emission tomography for the evaluation after treatment of localized prostate cancer Eur Urol 44 32 38 12814672 10.1016/S0302-2838(03)00207-0 (Pubitemid 36741372)
20. 18F]fluorocholine PET/CT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients Eur J Nucl Med Mol Imaging 33 1387 1398 16865395 10.1007/s00259-006-0150-2 (Pubitemid 44885404)
21. M. Heinisch A. Dirisamer W. Loidl F. Stoiber B. Gruy S. Haim, et al. 2006 Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml? Mol Imaging Biol 8 43 48 16315004 10.1007/s11307-005-0023-2 (Pubitemid 44193401)
22. D.B. Husarik R. Miralbell M. Dubs H. John O.T. Giger A. Gelet, et al. 2008 Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer Eur J Nucl Med Mol Imaging 35 253 263 17926036 10.1007/s00259-007-0552-9
23. G. Giovacchini M. Picchio E. Coradeschi V. Bettinardi L. Gianolli V. Scattoni, et al. 2010 Predictive factors of [(11)C] choline PET/CT in patients with biochemical failure after radical prostatectomy Eur J Nucl Med Mol Imaging 37 301 309 19756592 10.1007/s00259-009-1253-3
24. 11C-choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy J Nucl Med 50 1394 1400 19690023 10.2967/jnumed.108.061507
25. 11C-choline and FDG-PET in the diagnosis of biochemical prostate cancer relapse after radical treatment Mol Imaging Biol 12 210 217 19543774 10.1007/s11307-009-0243-y
26. A.J. Breeuwsma J. Pruim A.C. van den Bergh A.M. Leliveld R.J. Nijman R.A. Dierckx, et al. 2010 Detection of local, regional, and distant recurrence in patients with PSA relapse after external-beam radiotherapy using (11)C-choline positron emission tomography Int J Radiat Oncol Biol Phys 77 160 164 19783375 10.1016/j.ijrobp.2009.04.090
27. J.R. García M. Soler M.A. Blanch I. Ramírez E. Riera P. Lozano, et al. 2009 PET/CT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer Rev Esp Med Nucl 28 95 100 19558948 10.1016/S0212-6982(09)71350-3
28. R. Coleman T. DeGrado S. Wang S. Baldwin M. Orr R. Reiman, et al. 2000 Preliminary evaluation of F-18 fluorocholine (FCH) as a PET tumor imaging agent Clin Positron Imaging 3 147 11150750 10.1016/S1095-0397(00)00059-5
29. 11C-choline- positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer BJU Int 102 446 451 18410442 10.1111/j.1464-410X.2008.07592.x (Pubitemid 352032836)
30. 11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy Eur Urol 52 423 429 17397992 10.1016/j.eururo.2007.03.032 (Pubitemid 46963456)